BACKGROUND
Amantadine is the most commonly used pharmacologic treatment for levodopa-related dyskinesias (LRD), yet its efficacy and tolerability vary substantially, challenging clinical decision-making.
OBJECTIVE
To explore clinical, demographic, and genetic factors associated with variability in amantadine treatmen...
H. M. Chaparro-Solano, L. Saadatpour, J. Yu et al.· Parkinsonism & Related Disor...· 0 citations
Recent evidence suggests that TMEM106B expression is reduced in the brains of patients with Parkinson's disease (PD). However, an association between rare genetic variants in TMEM106B and PD risk has not been previously established. In this work, we investigated the association between rare TMEM106B variants and PD ris...
H. M. Chaparro-Solano, S. Kanagasingam, Z. Gan-or et al.· medRxiv· 0 citations
By expanding the reported spectrum of disease-associated variants in a Latin American population, this work identified previously unreported or underrepresented variants that would likely be missed by array-based or targeted screening approaches and contribute to the characterization of EOPD and familial PD in Latin Am...
E. Waldo, H. M. Chaparro-Solano, M. Isayan et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.